| Timothy Scharold Md Llc | |
|
1 Mallett Way Bluffton SC 29910-6067 | |
| (843) 682-4868 | |
| (843) 815-5650 |
| Full Name | Timothy Scharold Md Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1 Mallett Way, Bluffton, South Carolina |
| Authorized Official Name and Position | Timothy Scharold (PRESIDENT) |
| Authorized Official Contact | 8433422354 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Scharold Md Llc 32 Oyster Reef Dr Hilton Head SC 29926-2617 Ph: (843) 342-2354 | Timothy Scharold Md Llc 1 Mallett Way Bluffton SC 29910-6067 Ph: (843) 682-4868 |
| NPI Number | 1013228931 |
|---|---|
| Provider Enumeration Date | 06/24/2010 |
| Last Update Date | 06/24/2010 |
| Medicare PECOS PAC ID | 4981898947 |
|---|---|
| Medicare Enrollment ID | O20101103000865 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013228931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | SC26494 (South Carolina) | Primary |
| Provider Name | Timothy A Scharold |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114011947 PECOS PAC ID: 8123911070 Enrollment ID: I20040204000708 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
› Verified 1 days ago
| Provider Name | Elizabeth F Snyder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023146412 PECOS PAC ID: 0042375073 Enrollment ID: I20090209000036 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
› Verified 1 days ago
| Provider Name | Kristin Gavin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750922894 PECOS PAC ID: 7911355219 Enrollment ID: I20231128000195 |
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
› Verified 1 days ago
News Archive
Research from the University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
› Verified 1 days ago
Soler Medical Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 107 Seagrass Station Rd, Bluffton, SC 29910 Phone: 843-836-8227 | |
Medical Associates Of The Lowcountry Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 75 Baylor Dr Ste 155, Bluffton, SC 29910 Phone: 843-706-2523 Fax: 843-706-2527 | |
Burnt Church Primary And Urgent Care, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Burnt Church Rd, Bluffton, SC 29910 Phone: 843-757-9229 | |
Vital Personalized Healthcare, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 23 Plantation Park Dr, Bldg 400, Bluffton, SC 29910 Phone: 803-460-5699 | |
Medical Associates Of The Lowcountry Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 75 Baylor Drive, Suite 155, Bluffton, SC 29910 Phone: 843-706-2523 Fax: 843-706-2527 | |
Medical Consultants Of The Lowcountry Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 Seagrass Station Rd, Bluffton, SC 29910 Phone: 843-681-6122 Fax: 843-689-8112 |